Jonathan Talamo resigned as Ocular Therapeutix Inc.'s chief medical officer, effective June 15.
Discover more about S&P Global’s offerings
Ocular Therapeutix chief medical officer resigns
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Jonathan Talamo resigned as Ocular Therapeutix Inc.'s chief medical officer, effective June 15.